Cargando…

Interim effect evaluation of the hepatitis C elimination programme in Georgia: a modelling study

BACKGROUND: Georgia has a high prevalence of hepatitis C, with 5·4% of adults chronically infected. On April 28, 2015, Georgia launched a national programme to eliminate hepatitis C by 2020 (90% reduction in prevalence) through scaled-up treatment and prevention interventions. We evaluated the inter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Walker, Josephine G, Kuchuloria, Tinatin, Sergeenko, David, Fraser, Hannah, Lim, Aaron G, Shadaker, Shaun, Hagan, Liesl, Gamkrelidze, Amiran, Kvaratskhelia, Valeri, Gvinjilia, Lia, Aladashvili, Malvina, Asatiani, Alexander, Baliashvili, Davit, Butsashvili, Maia, Chikovani, Ivdity, Khonelidze, Irma, Kirtadze, Irma, Kuniholm, Mark H, Otiashvili, David, Sharvadze, Lali, Stvilia, Ketevan, Tsertsvadze, Tengiz, Zakalashvili, Mamuka, Hickman, Matthew, Martin, Natasha K, Morgan, Juliette, Nasrullah, Muazzam, Averhoff, Francisco, Vickerman, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025283/ https://www.ncbi.nlm.nih.gov/pubmed/31864917 http://dx.doi.org/10.1016/S2214-109X(19)30483-8

Ejemplares similares

Progress in Testing for and Treatment of Hepatitis C Virus Infection Among Persons Who Inject Drugs — Georgia, 2018
por: Stvilia, Ketevan, et al.
Publicado: (2019)

The Role of Screening and Treatment in National Progress Toward Hepatitis C Elimination — Georgia, 2015–2016
por: Nasrullah, Muazzam, et al.
Publicado: (2017)

Treatment outcomes of patients with chronic hepatitis C receiving sofosbuvir-based combination therapy within national hepatitis C elimination program in the country of Georgia
por: Tsertsvadze, Tengiz, et al.
Publicado: (2020)

Feasibility and effectiveness of HCV viraemia testing at harm reduction sites in Georgia: A prospective three‐arm study
por: Shilton, Sonjelle, et al.
Publicado: (2022)

High sustained viral response among HCV genotype 3 patients with advanced liver fibrosis: real-world data of HCV elimination program in Georgia
por: Butsashvili, Maia, et al.
Publicado: (2020)

Hepatitis C care cascade among patients with and without tuberculosis: Nationwide observational cohort study in the country of Georgia, 2015–2020
por: Baliashvili, Davit, et al.
Publicado: (2023)

Barriers of linkage to HCV viremia testing among people who inject drugs in Georgia
por: Butsashvili, Maia, et al.
Publicado: (2022)

Launch of a Nationwide Hepatitis C Elimination Program — Georgia, April 2015
por: Mitruka, Kiren, et al.
Publicado: (2015)

Policing, massive street drug testing and poly-substance use chaos in Georgia – a policy case study
por: Otiashvili, David, et al.
Publicado: (2016)

Retreatment of Chronic Hepatitis C Infection: Real-World Regimens and Outcomes From National Treatment Programs in Three Low- and Middle-Income Countries
por: Boeke, Caroline E, et al.
Publicado: (2021)

Drug preparation, injection, and sharing practices in Tajikistan: a qualitative study in Kulob and Khorog
por: Otiashvili, David, et al.
Publicado: (2016)

Toward reaching hepatitis B goals: hepatitis B epidemiology and the impact of two decades of vaccination, Georgia, 2021
por: Khetsuriani, Nino, et al.
Publicado: (2023)

Perceived acceptability of and willingness to use syringe vending machines: results of a cross-sectional survey of out-of-service people who inject drugs in Tbilisi, Georgia
por: Otiashvili, David, et al.
Publicado: (2019)

Costs of syringe vending machines in Tbilisi, Georgia
por: Walker, Josephine G., et al.
Publicado: (2023)

Hidden populations: risk behaviours in drug-using populations in the Republic of Georgia through subsequent peer-driven interventions
por: Lawlor, Cale, et al.
Publicado: (2021)

Reduction in Blood Lead Concentration in Children across the Republic of Georgia following Interventions to Address Widespread Exceedance of Reference Value in 2019
por: Ruadze, Ekaterine, et al.
Publicado: (2021)

Female partners of opioid-injecting men in the Republic of Georgia: an initial characterization
por: Lund, Ingunn O, et al.
Publicado: (2012)

Factors that influence the characteristics of needles and syringes used by people who inject drugs in Tajikistan
por: Zule, William A., et al.
Publicado: (2015)

The impact of the COVID-19 pandemic on illicit drug supply, drug-related behaviour of people who use drugs and provision of drug related services in Georgia: results of a mixed methods prospective cohort study
por: Otiashvili, David, et al.
Publicado: (2022)

An evaluation of the hepatitis C testing, care and treatment program in the country of Georgia’s corrections system, December 2013 – April 2015
por: Harris, Aaron M., et al.
Publicado: (2019)

Hantavirus Infection in the Republic of Georgia
por: Kuchuloria, Tinatin, et al.
Publicado: (2009)

Identifying Sources of Lead Exposure for Children in the Republic of Georgia, with Lead Isotope Ratios
por: Leonardi, Giovanni S., et al.
Publicado: (2023)

Process and Product in Cross-Cultural Treatment Research: Development of a Culturally Sensitive Women-Centered Substance Use Intervention in Georgia
por: Jones, Hendrée E., et al.
Publicado: (2014)

Feasibility and initial efficacy of a culturally sensitive women-centered substance use intervention in Georgia: Sex risk outcomes
por: Jones, Hendrée E., et al.
Publicado: (2015)

Risk factors and genotype distribution of hepatitis C virus in Georgia: A nationwide population-based survey
por: Baliashvili, Davit, et al.
Publicado: (2022)

Insights from a national survey in 2021 and from modelling on progress towards hepatitis C virus elimination in the country of Georgia since 2015
por: Walker, Josephine G., et al.
Publicado: (2023)

Crimean-Congo Hemorrhagic Fever in Man, Republic of Georgia, 2009
por: Zakhashvili, Khatuna, et al.
Publicado: (2010)

Methylenetetrahydrofolate Reductase (MTHFR) C677T and A1298C Polymorphisms in Georgian Females with Hypothyroidism
por: Kvaratskhelia, Tamar, et al.
Publicado: (2020)

Multimodal Functionalities of HIV-1 Integrase
por: Engelman, Alan N., et al.
Publicado: (2022)

Hepatitis C prevalence and risk factors in Georgia, 2015: setting a baseline for elimination
por: Hagan, Liesl M., et al.
Publicado: (2019)

Home-based hepatitis C self-testing in people who inject drugs and men who have sex with men in Georgia: a protocol for a randomised controlled trial
por: Shilton, Sonjelle, et al.
Publicado: (2022)

Factors associated with loss to follow-up among people with tuberculosis in the country of Georgia: a cohort study
por: Adamashvili, Natalia, et al.
Publicado: (2021)

The Prevalence of Malocclusion and Periodontal Diseases and Their Correlation in Samegrelo Region, Georgia
por: Kvaratskhelia, Sopiko, et al.
Publicado: (2022)

The prevalence of hyperglycemia and its impact on mortality among people living with HIV in Georgia
por: Borkowska, Tea, et al.
Publicado: (2022)

Molecular mechanisms of retroviral integration site selection
por: Kvaratskhelia, Mamuka, et al.
Publicado: (2014)

Generational differences in current sexual behavior among Georgian reproductive-aged women
por: Abzianidze, Tinatin, et al.
Publicado: (2019)

May Measurement Month 2018: an analysis of blood pressure screening results in Georgia
por: Tsinamdzgvrishvili, Bezhan, et al.
Publicado: (2020)

Human T-lymphotropic virus type 1 p30 interacts with REGγ and ATM (Ataxia Telangiectasia Mutated) to promote cell survival
por: Anupam, Rajaneesh, et al.
Publicado: (2011)

Virologic outcomes of second-line antiretroviral therapy in Eastern European country of Georgia
por: Chkhartishvili, Nikoloz, et al.
Publicado: (2014)

Rethinking the COVID-19 Pandemic: Back to Public Health
por: Collins, Téa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0rj3ka29g7t70n4l43qtnsh7m1